Pesquisa | BVS CLAP/SMR-OPAS/OMS

1.

American Cancer Society prostate cancer survivorship care guidelines.

Skolarus, Ted A; Wolf, Andrew M D; Erb, Nicole L; Brooks, Durado D; Rivers, Brian M; Underwood, Willie; Salner, Andrew L; Zelefsky, Michael J; Aragon-Ching, Jeanny B; Slovin, Susan F; Wittmann, Daniela A; Hoyt, Michael A; Sinibaldi, Victoria J; Chodak, Gerald; Pratt-Chapman, Mandi L; Cowens-Alvarado, Rebecca L.

CA Cancer J Clin ; 64(4): 225-49, 2014.

Artigo em Inglês | MEDLINE | ID: mdl-24916760

2.

A decision aid for teaching limitations of prostate cancer screening.

Weinrich, Sally P; Seger, Rachelle E; Rao, Ganesh S; Chan, Evelyn C; Hamm, Robert M; Godley, Paul A; Moul, Judd W; Powell, Isaac J; Chodak, Gerald W; Taylor, Kathryn L; Weinrich, Martin C.

J Natl Black Nurses Assoc ; 19(1): 1-11, 2008 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-18807773

3.

Combined androgen blockade in advanced prostate cancer: looking back to move forward.

Chodak, Gerald; Gomella, Leonard; Phung, De H.

Clin Genitourin Cancer ; 5(6): 371-8, 2007 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-17956709

4.

Critical review of complementary therapies for prostate cancer.

Wilkinson, Simon; Chodak, Gerald W.

J Clin Oncol ; 21(11): 2199-210, 2003 Jun 01.

Artigo em Inglês | MEDLINE | ID: mdl-12775747

5.

[Usefulness and positioning of MAB therapy for prostate cancer].

Akaza, Hideyuki; Chodak, Gerald W; Hirao, Yoshihiko.

Gan To Kagaku Ryoho ; 32(10): 1507-20, 2005 Oct.

Artigo em Japonês | MEDLINE | ID: mdl-16227758

6.

Lower baseline prostate-specific antigen is associated with a greater overall survival benefit from sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trial.

Schellhammer, Paul F; Chodak, Gerald; Whitmore, James B; Sims, Robert; Frohlich, Mark W; Kantoff, Philip W.

Urology ; 81(6): 1297-302, 2013 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-23582482

7.

Natural history of early localized prostate cancer.

Osborn, Jonathan R; Chodak, Gerald W.

JAMA ; 292(13): 1549; author reply 1549-50, 2004 Oct 06.

Artigo em Inglês | MEDLINE | ID: mdl-15467049

8.

Editorial comment.

Chodak, Gerald W.

Urology ; 81(4): 852; discussion 852, 2013 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-23465167

9.

Do "rapid" PSA assays reduce anxiety and stress of prostate cancer patients undergoing regular review? A prospective evaluation.

Wilkinson, Simon; Warren, Katherine; Ramsden, Alistair; Matthews, Alicia; Chodak, Gerald.

Urology ; 71(4): 567-72, 2008 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-18387384

10.

Prostate cancer: epidemiology, screening, and biomarkers.

Chodak, Gerald.

Rev Urol ; 8 Suppl 2: S3-8, 2006.

Artigo em Inglês | MEDLINE | ID: mdl-17021639

11.

Assessment of American urologists' approach to hormonal management of prostate cancer.

Warren, Katherine S; Osborn, Jonathan; Chodak, Gerald W.

Urology ; 68(6): 1305-7, 2006 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-17169651

12.

The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup.

McLeod, David G; See, William A; Klimberg, Ira; Gleason, Donald; Chodak, Gerald; Montie, James; Bernstein, Gregory; Morris, Clive; Armstrong, Jonathon.

J Urol ; 176(1): 75-80, 2006 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-16753373

13.

Maximum androgen blockade: a clinical update.

Chodak, Gerald W.

Rev Urol ; 7 Suppl 5: S13-7, 2005.

Artigo em Inglês | MEDLINE | ID: mdl-16985879

14.

Editorial comment.

Chodak, Gerald W.

Urology ; 75(5): 1027-8; author reply 1028, 2010 May.

Artigo em Inglês | MEDLINE | ID: mdl-20451710

15.

A critical review of maximal androgen blockade for advanced prostate cancer.

Chodak, Gerald W.

Rev Urol ; 6 Suppl 8: S18-23, 2004.

Artigo em Inglês | MEDLINE | ID: mdl-16985916

16.

An evaluation of intermediate-dose ketoconazole in hormone refractory prostate cancer.

Wilkinson, Simon; Chodak, Gerald.

Eur Urol ; 45(5): 581-4; discussion 585, 2004 May.

Artigo em Inglês | MEDLINE | ID: mdl-15082199

17.

The role of 111indium-capromab pendetide imaging for assessing biochemical failure after radical prostatectomy.

Wilkinson, Simon; Chodak, Gerald.

J Urol ; 172(1): 133-6, 2004 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-15201753

18.

Educating African-American men about prostate cancer: impact on awareness and knowledge.

Wilkinson, Simon; List, Marcy; Sinner, Michael; Dai, Lanting; Chodak, Gerald.

Urology ; 61(2): 308-13, 2003 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-12597936

19.

Attitudes and use of complementary medicine in men with prostate cancer.

Wilkinson, Simon; Gomella, Leonard G; Smith, Joseph A; Brawer, Michael K; Dawson, Nancy A; Wajsman, Zev; Dai, Lanting; Chodak, Gerald W.

J Urol ; 168(6): 2505-9, 2002 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-12441950

20.

Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer program.

Iversen, Peter; Wirth, Manfred P; See, William A; McLeod, David G; Klimberg, Ira; Gleason, Donald; Chodak, Gerald; Montie, James; Tyrrell, Chris; Wallace, D M A; Delaere, Karl P J; Lundmo, Per; Tammela, Teuvo L J; Johansson, Jan-Erik; Morris, Tom; Carroll, Kevin.

Urology ; 63(5): 928-33, 2004 May.

Artigo em Inglês | MEDLINE | ID: mdl-15134983

BVS CLAP/SMR-OPAS/OMS

Centro Latino Americano de Perinatologia, Saúde da Mulher e Reprodutiva

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

American Cancer Society prostate cancer survivorship care guidelines.

A decision aid for teaching limitations of prostate cancer screening.

Combined androgen blockade in advanced prostate cancer: looking back to move forward.

Critical review of complementary therapies for prostate cancer.

[Usefulness and positioning of MAB therapy for prostate cancer].

Lower baseline prostate-specific antigen is associated with a greater overall survival benefit from sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trial.

Natural history of early localized prostate cancer.

Editorial comment.

Do "rapid" PSA assays reduce anxiety and stress of prostate cancer patients undergoing regular review? A prospective evaluation.

Prostate cancer: epidemiology, screening, and biomarkers.

Assessment of American urologists' approach to hormonal management of prostate cancer.

The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup.

Maximum androgen blockade: a clinical update.

Editorial comment.

A critical review of maximal androgen blockade for advanced prostate cancer.

An evaluation of intermediate-dose ketoconazole in hormone refractory prostate cancer.

The role of 111indium-capromab pendetide imaging for assessing biochemical failure after radical prostatectomy.

Educating African-American men about prostate cancer: impact on awareness and knowledge.

Attitudes and use of complementary medicine in men with prostate cancer.

Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer program.